QuidelOrthoQDEL -3.92%47 Days Payable is 67.01 as of Mar. 2026, which is 2% above its 10-year median of 65.44. GuruFocus rates QDEL with a GF Score™ of 47/100 and a GF Value™ of $37.28 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 795 Medical Devices & Instruments companies, QuidelOrtho ranks worse than 59.5% on this metric.
The historical rank and industry rank for QuidelOrtho's Days Payable or its related term are showing as below:
QDEL'
s Days Payable Range Over the Past 10 Years
Min: 44.22 Med: 65.44 Max: 81.55
Current: 59.21
During the past 13 years, QuidelOrtho's highest Days Payable was 81.55. The lowest was 44.22. And the median was 65.44.
QDEL's Days Payable is ranked worse than 59.5% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs QDEL: 59.21
QuidelOrtho's Days Payable
increased
from Mar. 2025 (62.26) to Mar. 2026 (67.01).
It may suggest that QuidelOrthodelayed paying its suppliers.
QuidelOrtho Days Payable Related Terms
QuidelOrtho Days Payable Historical Data
* Premium members only.
The historical data trend for QuidelOrtho's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, QuidelOrtho's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QuidelOrtho Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Days Payable distribution charts can be found below:
* The bar in red indicates where QuidelOrtho's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
QuidelOrtho's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QuidelOrtho (QDEL) has a Days Payable of 67.01 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on QuidelOrtho and its competitors. This is near median its historical median of 65.44. Over the past decade, QuidelOrtho's Days Payable has ranged from 44.22 to 81.55. According to the industry distribution chart, QuidelOrtho ranks #473 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 59.5%.
Is QuidelOrtho's Days Payable too high?
QuidelOrtho's current Days Payable of 67.01 is near median its 10-year median of 65.44. Over the past 10 years, this metric has ranged from a low of 44.22 to a high of 81.55. The Medical Devices & Instruments industry median Days Payable is 68.07. QuidelOrtho's value of 67.01 is 1.6% below this industry median. Based on the distribution chart, QuidelOrtho ranks #473 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, QuidelOrtho has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Days Payable compare to AVR and INMD?
According to the Medical Devices & Instruments industry distribution chart, QuidelOrtho ranks #473 out of 795 companies for Days Payable. This places QuidelOrtho in the lower half of its industry. The industry median Days Payable is 68.07. QuidelOrtho's value of 67.01 is 1.6% below this benchmark. Historically, QuidelOrtho's own Days Payable has ranged from 44.22 to 81.55 over the past decade. While the company's 10-year median is 65.44 vs. the industry median of 68.07, QuidelOrtho has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QuidelOrtho's current Days Payable of 67.01 is 1.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on QuidelOrtho and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QuidelOrtho's current Days Payable is 67.01, which is near median its own 10-year median of 65.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
Based on GuruFocus' analysis, QuidelOrtho (QDEL) is currently considered Possible Value Trap. The stock's GF Value™ is $37.28, compared to a current price of $17.52 — trading 53% below its estimated fair value. The current Days Payable is 67.01, which is near median its 10-year median of 65.44 and 1.6% below the Medical Devices & Instruments industry median of 68.07. QuidelOrtho's overall GF Score™ is 47/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For QuidelOrtho (QDEL), the current Days Payable is 67.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QuidelOrtho (QDEL) Overvalued in 2026?
Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued.
The current stock price of $17.52 is trading 53% below its estimated GF Value™ of $37.28.
GuruFocus considers QuidelOrtho to be Possible Value Trap.
Key valuation signals for QDEL:
Days Payable: 67.01 (near median its 10-year median of 65.44)
GF Value™: $37.28 vs. price of $17.52 (53% below fair value)
Industry Position: 1.6% below the Medical Devices & Instruments median (#473 of 795)
No single metric tells the full story. See the QDEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
47GF Score
Get the complete analysis for QDEL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QDEL has been successfully added to your 
